The HER2 signaling network in human heart failure, implication for brest cancer treatment

被引：0
|
作者：
Leszek, P. [1 ]
Stachurska, A. [2 ,3 ]
Kusmierczyk, M. [1 ]
Kolsut, P. [1 ]
Szafron, L. [2 ,3 ]
Jagielska, B. [2 ,3 ]
Rywik, T. [1 ]
机构：
[1] Inst Cardiol, Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6159
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
  • [41] HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer
    De Cuyper, Astrid
    Van Den Eynde, Marc
    Machiels, Jean-Pascal
    CLINICAL COLORECTAL CANCER, 2020, 19 (02) : 65 - 72
  • [42] EGFR, HER2 and VEGF PathwaysValidated Targets for Cancer Treatment
    Michael F. Press
    Heinz-Josef Lenz
    Drugs, 2007, 67 : 2045 - 2075
  • [43] HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
    Kavuri, Shyam M.
    Jain, Naveen
    Galimi, Francesco
    Cottino, Francesca
    Leto, Simonetta M.
    Migliardi, Giorgia
    Searleman, Adam C.
    Shen, Wei
    Monsey, John
    Trusolino, Livio
    Jacobs, Samuel A.
    Bertotti, Andrea
    Bose, Ron
    CANCER DISCOVERY, 2015, 5 (08) : 832 - 841
  • [44] Evaluating Trastuzumab in the treatment of HER2 positive breast cancer
    Jaques, Ryan
    Xu, Sam
    Matsakas, Antonios
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (10) : 1059 - 1075
  • [45] Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer
    Mu, Yuxin
    Meng, Yanchun
    Du, Yiqun
    Liu, Xiaojun
    Zhang, Jian
    THORACIC CANCER, 2023, 14 (34) : 3381 - 3388
  • [46] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Stanowicka-Grada, Malwina
    Senkus, Elzbieta
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650
  • [47] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [48] HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer
    Mazumder, Aloran
    Shiao, Stephen
    Haricharan, Svasti
    ENDOCRINOLOGY, 2021, 162 (10)
  • [49] Loss of HER2 after neoadjuvant treatment of HER2+early breast cancer
    Morales, S.
    Gasol Cudos, A.
    Rodriguez Galindo, A.
    Velasco, A.
    Canosa Morales, C.
    Sanchez Guzman, D. -R.
    Mele Olive, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S51 - S51
  • [50] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Malwina Stanowicka-Grada
    Elżbieta Senkus
    Current Treatment Options in Oncology, 2023, 24 : 1633 - 1650
12345